This post is from a suggested group
The Global Osteoarthritis Treatment Market: Advancing Beyond Symptom Relief with Biologics, Regenerative Medicine, and Disease-Modifying Therapies
The Global Osteoarthritis (OA) Treatment Market is undergoing a profound transformation, shifting its focus from mere symptom management to developing disease-modifying treatments and regenerative therapies. The market is experiencing robust growth, primarily driven by the escalating global incidence of OA, which is closely tied to the rapidly aging population and the rise in obesity rates—both significant risk factors for this degenerative joint disease. While conventional pharmacological treatments, such as oral and topical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and intra-articular corticosteroid injections, remain the foundational therapies for pain and inflammation relief, the market's value is increasingly propelled by high-growth segments like Biologics and Regenerative Medicine. This includes the use of Platelet-Rich Plasma (PRP) and Mesenchymal Stem Cell (MSC) therapies, which aim to slow disease progression, repair damaged cartilage, and restore joint function, offering the promise of…